Authors:
GIDAL BE
MALY MM
KOWALSKI JW
RUTECKI PA
PITTERLE ME
COOK DE
Citation: Be. Gidal et al., GABAPENTIN ABSORPTION - EFFECT OF MIXING WITH FOODS OF VARYING MACRONUTRIENT COMPOSITION, The Annals of pharmacotherapy, 32(4), 1998, pp. 405-409
Citation: Nm. Graves et al., THE NEW-GENERATION OF ANTIEPILEPTIC DRUGS - UNRESOLVED QUESTIONS, The Annals of pharmacotherapy, 32(11), 1998, pp. 1239-1243
Authors:
GIDAL BE
DECERCE J
BOCKBRADER HN
GONZALEZ J
KRUGER S
PITTERLE ME
RUTECKI P
RAMSAY RE
Citation: Be. Gidal et al., GABAPENTIN BIOAVAILABILITY - EFFECT OF DOSE AND FREQUENCY OF ADMINISTRATION IN ADULT PATIENTS WITH EPILEPSY, Epilepsy research, 31(2), 1998, pp. 91-99
Authors:
CHANT C
FAGAN SC
AURORA SK
GIDAL BE
JOSEPH R
Citation: C. Chant et al., EFFECTS OF ASPIRIN ON PLATELET-AGGREGATION IN SMOKERS AND NONSMOKERS, The Annals of pharmacotherapy, 31(3), 1997, pp. 290-293
Authors:
GIDAL BE
RUTECKI P
SHAW R
MALY MM
COLLINS DM
PITTERLE ME
Citation: Be. Gidal et al., EFFECT OF LAMOTRIGINE ON CARBAMAZEPINE EPOXIDE CARBAMAZEPINE SERUM CONCENTRATION RATIOS IN ADULT PATIENTS WITH EPILEPSY, Epilepsy research, 28(3), 1997, pp. 207-211
Authors:
GIDAL BE
INGLESE CM
MEYER JF
PITTERLE ME
ANTONOPOLOUS J
RUST RS
Citation: Be. Gidal et al., DIET-INDUCED AND VALPROATE-INDUCED TRANSIENT HYPERAMMONEMIA - EFFECT OF L-CARNITINE, Pediatric neurology, 16(4), 1997, pp. 301-305
Citation: Gl. Lensmeyer et al., OPTIMIZED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR DETERMINATION OF LAMOTRIGINE IN SERUM WITH CONCOMITANT DETERMINATION OF PHENYTOIN, CARBAMAZEPINE, AND CARBAMAZEPINE EPOXIDE, Therapeutic drug monitoring, 19(3), 1997, pp. 292-300
Citation: Be. Gidal et al., CHANGES IN INTERLEUKIN-6 CONCENTRATIONS FOLLOWING EPILEPSY SURGERY - POTENTIAL INFLUENCE ON CARBAMAZEPINE PHARMACOKINETICS, The Annals of pharmacotherapy, 30(5), 1996, pp. 545-546
Authors:
GIDAL BE
CRISMON ML
WAGNER ML
FAGAN SC
PRIVITERA MD
DALMADYISRAEL C
GRAVES NM
Citation: Be. Gidal et al., CURRENT DEVELOPMENTS IN NEUROLOGY .2. ADVANCES IN THE PHARMACOTHERAPYOF ALZHEIMER-DISEASE, PARKINSON DISEASE, AND STROKE, The Annals of pharmacotherapy, 30(12), 1996, pp. 1446-1451
Authors:
GIDAL BE
WAGNER ML
PRIVITERA MD
DALMADYISRAEL C
CRISMON ML
FAGAN SC
GRAVES NM
Citation: Be. Gidal et al., CURRENT DEVELOPMENTS IN NEUROLOGY .1. ADVANCES IN THE PHARMACOTHERAPYOF HEADACHE, EPILEPSY, AND MULTIPLE-SCLEROSIS, The Annals of pharmacotherapy, 30(11), 1996, pp. 1272-1276
Authors:
GIDAL BE
ANDERSON GD
SPENCER NW
MALY MM
MURTY J
PITTERLE ME
COLLINS DM
DAVIS LA
Citation: Be. Gidal et al., VALPROATE-ASSOCIATED WEIGHT-GAIN - POTENTIAL RELATION TO ENERGY-EXPENDITURE AND METABOLISM IN PATIENTS WITH EPILEPSY, Journal of epilepsy, 9(4), 1996, pp. 234-241
Authors:
BLACK DJ
KUNZE KL
WIENKERS LC
GIDAL BE
SEATON TL
MCDONNELL ND
EVANS JS
BAUWENS E
TRAGER WF
Citation: Dj. Black et al., WARFARIN-FLUCONAZOLE .2. A METABOLICALLY BASED DRUG-INTERACTION - IN-VIVO STUDIES, Drug metabolism and disposition, 24(4), 1996, pp. 422-428
Citation: Be. Gidal et al., EVALUATION OF CARBAMAZEPINE AND CARBAMAZEPINE-EPOXIDE PROTEIN-BINDINGIN PATIENTS UNDERGOING EPILEPSY SURGERY, Epilepsia, 37(4), 1996, pp. 381-385
Authors:
ANDERSON GD
YAU MK
GIDAL BE
HARRIS SJ
LEVY RH
LAI AA
WOLF KB
WARGIN WA
DREN AT
Citation: Gd. Anderson et al., BIDIRECTIONAL INTERACTION OF VALPROATE AND LAMOTRIGINE IN HEALTHY-SUBJECTS, Clinical pharmacology and therapeutics, 60(2), 1996, pp. 145-156